We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
-9.45%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.13B
AUM Growth
-$263M
Cap. Flow
-$67.3M
Cap. Flow %
-5.93%
Top 10 Hldgs %
53.9%
Holding
81
New
2
Increased
39
Reduced
9
Closed
6

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$23.3M
2
BVS icon
Bioventus
BVS
+$12.1M
3
PRTA icon
Prothena Corp
PRTA
+$7.77M
4
AXNX
Axonics, Inc. Common Stock
AXNX
+$7.75M
5
SIBN icon
SI-BONE Inc
SIBN
+$7.56M

Sector Composition

Rank Sector Weight
1 Healthcare 84.11%
2 Communication Services 6.42%
3 Energy 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANNX icon
76
Annexon
ANNX
$835M
-473,700
Closed -$5.44M
MRVI icon
77
Maravai LifeSciences
MRVI
$969M
-96,637
Closed -$4.05M
QDEL icon
78
QuidelOrtho
QDEL
$1.14B
-74,544
Closed -$10.1M
TEVA icon
79
Teva Pharmaceuticals
TEVA
$40.8B
-1,897,506
Closed -$15.2M
ARNA
80
DELISTED
Arena Pharmaceuticals Inc
ARNA
-645,848
Closed -$60M
ITMR
81
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
-355,410
Closed -$11M

Similar funds

First Light Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, First Light Asset Management held 81 positions worth $1.13B, down 19% from $1.4B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

First Light Asset Management withdrew a net $67.3M in Q1 2022, closing 6 positions and reducing 9 holdings. Its most notable exit was Arena Pharmaceuticals Inc, an estimated $60M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Communication Services and Energy.

Against the trend, First Light Asset Management opened a new position in Bioventus worth $12.7M.

  • First Light Asset Management's largest Q1 2022 buy was Bioventus: 901,525 shares worth $12.7M.
  • First Light Asset Management added most to AtriCure in Q1 2022, an estimated $23.3M increase.
  • First Light Asset Management's biggest Q1 2022 reduction was Intersect ENT, Inc, cutting an estimated $27.4M.
  • First Light Asset Management fully exited Arena Pharmaceuticals Inc in Q1 2022, selling an estimated $60M.
  • First Light Asset Management's ten largest holdings make up 54% of its $1.13B portfolio in Q1 2022.
  • First Light Asset Management opened 2 new positions and closed 6 in Q1 2022.
  • First Light Asset Management's portfolio value fell 19% quarter-over-quarter to $1.13B.

Based on First Light Asset Management's 13F filing for Q1 2022, filed 13 May 2022.